Skip to content
healthcare.dev

TABRECTA

NDC 0078-0709, capmatinib, tablet, film coated, from Novartis Pharmaceuticals Corporation.

Product NDC
0078-0709
Status
Listed
Labeler
Novartis Pharmaceuticals Corporation
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA213591
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0709 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CAPMATINIB HYDROCHLORIDE150 mg/1

Pharmacologic classes

Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 1A2 Inhibitors [MoA]; Kinase Inhibitor [EPC]; Mesenchymal Epithelial Transition Inhibitors [MoA]; Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]; Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]

Package NDCNDC-11Package
0078-0709-560007807095656 TABLET, FILM COATED in 1 BOTTLE (0078-0709-56)
0078-0709-940007807099456 TABLET, FILM COATED in 1 BOTTLE (0078-0709-94)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/455892c3-d144-4ba8-9ab4-79cabff9876d

Use it

Look up 0078-0709 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0709 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0078-0709. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.